What is he best known for?
The fields of study he is best known for:
His primary areas of study are Biochemistry, Internal medicine, Endocrinology, Apolipoprotein B and Phospholipid.
His Biochemistry research is multidisciplinary, incorporating elements of Adhesion and Molecular biology.
The various areas that Henry J. Pownall examines in his Internal medicine study include Diabetes mellitus, Type 2 diabetes and Physical therapy.
Henry J. Pownall has included themes like Receptor, Apolipoprotein E and Signal transduction in his Endocrinology study.
His Apolipoprotein B research is multidisciplinary, incorporating perspectives in Human plasma, Very low-density lipoprotein and Protein–protein interaction.
His Phospholipid study combines topics in areas such as Crystallography and NEFA.
His most cited work include:
- Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. (1600 citations)
- Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. (935 citations)
- Association of an intensive lifestyle intervention with remission of type 2 diabetes. (370 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Biochemistry, Internal medicine, Endocrinology, Cholesterol and Apolipoprotein B.
His studies in Lipoprotein, Phospholipid, Sterol O-acyltransferase, Very low-density lipoprotein and Cholesteryl ester are all subfields of Biochemistry research.
His Phospholipid research includes elements of Crystallography, Vesicle, Chromatography and Biophysics.
His Internal medicine research integrates issues from Diabetes mellitus and Type 2 diabetes.
Endocrinology is often connected to Apolipoprotein E in his work.
His work in Weight loss addresses subjects such as Randomized controlled trial, which are connected to disciplines such as Overweight and Physical therapy.
He most often published in these fields:
- Biochemistry (37.93%)
- Internal medicine (34.75%)
- Endocrinology (30.77%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (34.75%)
- Endocrinology (30.77%)
- Cholesterol (26.53%)
In recent papers he was focusing on the following fields of study:
Henry J. Pownall mostly deals with Internal medicine, Endocrinology, Cholesterol, Reverse cholesterol transport and Biochemistry.
In his study, which falls under the umbrella issue of Internal medicine, Physical therapy and Hazard ratio is strongly linked to Type 2 diabetes.
In general Endocrinology study, his work on Cholesteryl ester and Lipid metabolism often relates to the realm of High density, Serum opacity factor and Mechanism, thereby connecting several areas of interest.
The study incorporates disciplines such as Alcohol and Metabolite in addition to Cholesterol.
His work on Apolipoprotein B, Phospholipid, Proline and Cytoplasm as part of general Biochemistry research is often related to Structure and function, thus linking different fields of science.
Henry J. Pownall has researched Weight loss in several fields, including Diabetes mellitus and Randomized controlled trial.
Between 2016 and 2021, his most popular works were:
- Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease (50 citations)
- Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease (50 citations)
- Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study (33 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Internal medicine, Apolipoprotein B, Reverse cholesterol transport, Type 2 diabetes and CRISPR.
His Apolipoprotein B research is multidisciplinary, relying on both Phospholipid and High-density lipoprotein.
Reverse cholesterol transport is the subject of his research, which falls under Endocrinology.
His study in Type 2 diabetes is interdisciplinary in nature, drawing from both Peripheral neuropathy, Weight loss, Overweight, Randomized controlled trial and Physical therapy.
His studies deal with areas such as Body mass index, Obesity, Diabetes mellitus and Clinical trial as well as Randomized controlled trial.
In general Biochemistry, his work in Cell, ABCA1 and Lipoprotein is often linked to Apolipoprotein AII linking many areas of study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
